Published in Eye (Lond) on January 09, 2009
Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer. Invest Ophthalmol Vis Sci (2013) 1.30
Absence of systemic immune response to adenovectors after intraocular administration to children with retinoblastoma. Mol Ther (2010) 1.23
Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infection. Prog Retin Eye Res (2012) 0.96
Localized retinal neuropeptide regulation of macrophage and microglial cell functionality. J Neuroimmunol (2010) 0.92
Gene expression and functional annotation of the human ciliary body epithelia. PLoS One (2012) 0.88
Applications of the role of α-MSH in ocular immune privilege. Adv Exp Med Biol (2010) 0.87
The neuropeptides α-MSH and NPY modulate phagocytosis and phagolysosome activation in RAW 264.7 cells. J Neuroimmunol (2013) 0.85
Regulation of CD8(+) T Cell Responses to Retinal Antigen by Local FoxP3(+) Regulatory T Cells. Front Immunol (2012) 0.84
Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane. Transl Vis Sci Technol (2014) 0.83
Following EAU recovery there is an associated MC5r-dependent APC induction of regulatory immunity in the spleen. Invest Ophthalmol Vis Sci (2011) 0.82
Autoimmune responses against photoreceptor antigens during retinal degeneration and their role in macrophage recruitment into retinas of RCS rats. J Neuroimmunol (2012) 0.82
Ocular Immune Privilege and Transplantation. Front Immunol (2016) 0.80
Alloimmunity and Tolerance in Corneal Transplantation. J Immunol (2016) 0.79
Macrophages and Uveitis in Experimental Animal Models. Mediators Inflamm (2015) 0.78
Bacterial tick-borne diseases caused by Bartonella spp., Borrelia burgdorferi sensu lato, Coxiella burnetii, and Rickettsia spp. among patients with cataract surgery. Med Sci Monit (2014) 0.78
Suppressive effect of aqueous humor on lipopolysaccharide-induced dendritic cell maturation. Jpn J Ophthalmol (2011) 0.78
The alpha-melanocyte stimulating hormone induces conversion of effector T cells into treg cells. J Transplant (2011) 0.78
Role of inflammation in endophthalmitis. Mediators Inflamm (2012) 0.78
Simultaneous Complement Response via Lectin Pathway in Retina and Optic Nerve in an Experimental Autoimmune Glaucoma Model. Front Cell Neurosci (2016) 0.77
Extravascular modified lipoproteins: a role in the propagation of diabetic retinopathy in a mouse model of type 1 diabetes. Diabetologia (2016) 0.76
The Effect of Transient Local Anti-inflammatory Treatment on the Survival of Pig Retinal Progenitor Cell Allotransplants. Transl Vis Sci Technol (2015) 0.76
Generation of Regulatory T Cells to Antigen Expressed in the Retina. Curr Immunol Rev (2015) 0.76
Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain. Front Pharmacol (2016) 0.75
MC5r and A2Ar Deficiencies During Experimental Autoimmune Uveitis Identifies Distinct T cell Polarization Programs and a Biphasic Regulatory Response. Sci Rep (2016) 0.75
Involvement of B cells in non-infectious uveitis. Clin Transl Immunology (2016) 0.75
Identification of intraocular inflammatory mediators in patients with endophthalmitis. Mol Vis (2016) 0.75
Traumatic endophthalmitis caused by Nocardia kruczakiae in a patient with traumatic eye injury. J Ophthalmic Inflamm Infect (2015) 0.75
Dependence of the lymphocyte proliferative response on the endogenous cortisol level and sensitivity to β-adrenergic regulation in vitro in the early period of penetrating eye injury. Dokl Biol Sci (2010) 0.75
The effect of polyoxidonium on immune response and morphological parameters of inflammation after experimental penetrating eye injury. Dokl Biol Sci (2012) 0.75
Effects of intravitreally injected Fc fragment on rat eyes. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Fas ligand-induced apoptosis as a mechanism of immune privilege. Science (1995) 8.23
Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med (2008) 5.25
Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol (2003) 3.74
The role of afferent lymphatics in the rejection of skin homografts. J Exp Med (1968) 2.60
Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol (1948) 2.53
The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J Exp Med (2005) 1.85
Immune response to immunization via the anterior chamber of the eye. I. F. lymphocyte-induced immune deviation. J Immunol (1977) 1.65
Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J Leukoc Biol (2003) 1.57
Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res (1992) 1.47
Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol (1998) 1.40
Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. Int Immunol (2007) 1.36
Thrombospondin plays a vital role in the immune privilege of the eye. Invest Ophthalmol Vis Sci (2005) 1.32
Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response. J Immunol (1997) 1.31
Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur J Immunol (1992) 1.29
Peptidergic innervation of the retinal vasculature and optic nerve head. Invest Ophthalmol Vis Sci (1990) 1.26
IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis. Invest Ophthalmol Vis Sci (2000) 1.25
Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J Immunol (1994) 1.24
Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology (1998) 1.23
The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides (1996) 1.17
Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor. Invest Ophthalmol Vis Sci (1998) 1.13
Inducible immune regulation following autoimmune disease in the immune-privileged eye. J Leukoc Biol (2005) 1.11
Aqueous humor induces transforming growth factor-beta (TGF-beta)-producing regulatory T-cells. Curr Eye Res (1997) 1.07
Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B lymphocytes. Immunology (1990) 1.07
Specific aqueous humor factors induce activation of regulatory T cells. Invest Ophthalmol Vis Sci (1999) 1.05
The eye's view of antigen presentation. Hum Immunol (2002) 1.05
The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages. J Neuroimmunol (2005) 1.04
Alpha-melanocyte-stimulating hormone suppresses antigen-stimulated T cell production of gamma-interferon. Neuroimmunomodulation (1996) 1.04
A deviant immune response to viral proteins and transgene product is generated on subretinal administration of adenovirus and adeno-associated virus. Mol Ther (2002) 1.04
Expression of thrombospondin in TGFbeta-treated APCs and its relevance to their immune deviation-promoting properties. J Immunol (2002) 1.01
Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms. Ocul Immunol Inflamm (2003) 1.01
The analysis of systemic tolerance elicited by antigen inoculation into the vitreous cavity: vitreous cavity-associated immune deviation. Immunology (2005) 0.99
Inhibition of endotoxin-induced uveitis and potentiation of cyclooxygenase-2 protein expression by alpha-melanocyte-stimulating hormone. Invest Ophthalmol Vis Sci (2004) 0.97
Inhibition of lymphocyte proliferation by aqueous humor. Reg Immunol (1990) 0.96
Ocular immune privilege and CD1d-reactive natural killer T cells. Cornea (2002) 0.94
Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye. Curr Eye Res (1991) 0.93
Analysis of immunomodulatory activities of aqueous humor from eyes of mice with experimental autoimmune uveitis. J Immunol (2000) 0.91
Somatostatin is an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci (2003) 0.90
Anti-inflammatory effects of alpha-melanocyte-stimulating hormone against rat endotoxin-induced uveitis and the time course of inflammatory agents in aqueous humor. Int Immunopharmacol (2004) 0.90
Effects of the COOH-terminal tripeptide alpha-MSH(11-13) on corneal epithelial wound healing: role of nitric oxide. Exp Eye Res (2006) 0.89
Expression of indoleamine 2,3-dioxygenase in human corneal cells as a local immunosuppressive factor. Invest Ophthalmol Vis Sci (2007) 0.87
B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells. Invest Ophthalmol Vis Sci (2006) 0.86
Systemic immune deviation in the brain that does not depend on the integrity of the blood-brain barrier. J Immunol (2000) 0.86
Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space. Invest Ophthalmol Vis Sci (1999) 0.83
Somatostatin and prosomatostatin in the retina of the rat: an immunohistochemical, in-situ hybridization, and chromatographic study. Vis Neurosci (1990) 0.82
Complement system and the eye. Adv Exp Med Biol (2006) 0.81